Morphic Holding, Inc. Banner Image

Morphic Holding, Inc. has reached its limit for free report views

Work for Morphic Holding, Inc.? Upgrade Your Profile and unlock all your annual reports.

Morphic Holding, Inc.

  • Ticker MORF
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Morphic Holding, Inc. Logo Image
  • 51-200 Employees
  • Based in Waltham, Massachusetts
Morphic Therapeutic is a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis and cancer. In collaboration with AbbVie, Janssen, and Schrödinger, Morphic is advancing its pipeline and discovery activities using its proprietary MInT technologyMore platform which leverages the Company’s unique understanding of integrin structure and biology.
Morphic Holding, Inc.

Most Recent Annual Report

Morphic Holding, Inc. MOST RECENT 2020 Annual Report and Form 10K

Report Locked. Morphic Holding, Inc. has reached its limit for free report views.

Older/Archived Annual Reports